Ansell Ltd (ASX: ANN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Ansell Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$4.91 billion
P/E Ratio
35.58
Dividend Yield
1.71%
Shares Outstanding
145.94 million
Earnings per share
0.591
Dividend per share
0.57
Year To Date Return
35.92%
Earnings Yield
2.81%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Ansell Ltd (ASX: ANN)
Latest News
Share Gainers
Why Afterpay, Ansell, MyDeal, & PolyNovo shares are storming higher today
Share Gainers
Why the Ansell (ASX:ANN) share price stormed 5% higher today
⏸️ ASX Shares
Top ASX shares to buy in 2021
Healthcare Shares
These are 8 of the best performing ASX healthcare shares of 2020 so far
52-Week Highs
Why ResMed (ASX:RMD) and these ASX shares just hit record highs
Share Market News
Top brokers name 3 ASX shares to sell next week
Share Market News
Leading brokers reiterate buy rating on this ASX healthcare share
Share Market News
6 major events for ASX shares this week
Record Highs
Here's why the Ansell (ASX:ANN) share price hit a record high today
Share Market News
ASX 200 rises, Bingo jumps after reporting
Share Market News
Ansell share price on watch after COVID demand drives strong FY 2020 growth
Share Market News
5 things to watch on the ASX 200 on Tuesday
Frequently Asked Questions
-
Yes, Ansell has historically paid two unfranked or partially franked dividends per year.
-
Ansell pays its shareholder dividends in March and September.
-
Ansell Ltd listed on the ASX on 22 August 1985.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 26 Aug 2024 | $0.3227 | 0.00% | Final | 12 Sep 2024 |
| 26 Feb 2024 | $0.2521 | 0.00% | Interim | 14 Mar 2024 |
| 18 Aug 2023 | $0.4031 | 0.00% | Final | 07 Sep 2023 |
| 20 Feb 2023 | $0.2915 | 0.00% | Interim | 09 Mar 2023 |
| 29 Aug 2022 | $0.4518 | 0.00% | Final | 15 Sep 2022 |
| 21 Feb 2022 | $0.3367 | 0.00% | Interim | 09 Mar 2022 |
| 30 Aug 2021 | $0.5944 | 0.00% | Final | 16 Sep 2021 |
| 22 Feb 2021 | $0.4190 | 0.00% | Interim | 10 Mar 2021 |
| 31 Aug 2020 | $0.3811 | 0.00% | Final | 17 Sep 2020 |
| 24 Feb 2020 | $0.3288 | 0.00% | Interim | 12 Mar 2020 |
| 16 Aug 2019 | $0.3833 | 0.00% | Final | 05 Sep 2019 |
| 22 Feb 2019 | $0.2905 | 0.00% | Interim | 14 Mar 2019 |
| 24 Aug 2018 | $0.3414 | 0.00% | Final | 13 Sep 2018 |
| 16 Feb 2018 | $0.2588 | 44.13% | Interim | 08 Mar 2018 |
| 18 Aug 2017 | $0.2998 | 0.00% | Final | 08 Sep 2017 |
| 17 Feb 2017 | $0.2638 | 0.00% | Interim | 10 Mar 2017 |
| 19 Aug 2016 | $0.3097 | 0.00% | Final | 08 Sep 2016 |
| 11 Feb 2016 | $0.2795 | 0.00% | Interim | 10 Mar 2016 |
| 13 Aug 2015 | $0.3119 | 0.00% | Final | 10 Sep 2015 |
| 12 Feb 2015 | $0.2567 | 0.00% | Interim | 11 Mar 2015 |
| 26 Feb 2014 | $0.1828 | 0.00% | Interim | 25 Mar 2014 |
| 16 Feb 2012 | $0.1050 | 0.00% | Interim | 14 Mar 2012 |
| 17 Feb 2011 | $0.0980 | 0.00% | Interim | 16 Mar 2011 |
| 31 Aug 2010 | $0.1225 | 0.00% | Final | 29 Sep 2010 |
| 02 Mar 2006 | $0.0630 | 0.00% | Interim | 07 Apr 2006 |
| 26 Sep 2005 | $0.0700 | 0.00% | Final | 18 Oct 2005 |
ANN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Ansell Ltd
Ansell Ltd (ASX: ANN) is a leading global supplier of protective gloves and bodywear for use in healthcare and industrial settings.
The company holds a large number of patents and the majority of sales come from its key branded product ranges. It earns the bulk of its revenue and profit from the healthcare segment and the remainder from its industrial business.
The Australian company has an international manufacturing and distribution footprint and supplies its products via key partners as well as directly across more than 100 countries.
Ansell earns the bulk of its revenue from its North American market segment followed by Europe, the Middle East, and Africa. The Asia-Pacific accounts for a relatively small portion of the company's business.
ANN Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 27 Dec 2024 | $33.66 | $0.01 | 0.03% | 141,367 | $33.50 | $33.78 | $33.40 |
| 24 Dec 2024 | $33.65 | $0.42 | 1.26% | 102,447 | $33.30 | $33.65 | $33.26 |
| 23 Dec 2024 | $33.23 | $0.26 | 0.79% | 173,000 | $32.97 | $33.23 | $32.78 |
| 20 Dec 2024 | $32.97 | $-0.02 | -0.06% | 533,568 | $32.67 | $33.09 | $32.66 |
| 19 Dec 2024 | $32.99 | $-0.69 | -2.05% | 378,238 | $33.30 | $33.33 | $32.99 |
| 18 Dec 2024 | $33.68 | $0.11 | 0.33% | 263,003 | $33.35 | $33.72 | $33.33 |
| 17 Dec 2024 | $33.57 | $0.64 | 1.94% | 276,991 | $32.76 | $33.57 | $32.75 |
| 16 Dec 2024 | $32.93 | $-0.07 | -0.21% | 360,923 | $32.95 | $33.12 | $32.75 |
| 13 Dec 2024 | $33.00 | $0.20 | 0.61% | 185,406 | $32.71 | $33.07 | $32.36 |
| 12 Dec 2024 | $32.80 | $0.21 | 0.64% | 417,229 | $32.88 | $33.00 | $32.62 |
| 11 Dec 2024 | $32.59 | $-0.50 | -1.51% | 191,586 | $33.00 | $33.14 | $32.32 |
| 10 Dec 2024 | $33.09 | $-0.65 | -1.93% | 284,652 | $33.93 | $33.95 | $33.05 |
| 09 Dec 2024 | $33.74 | $0.02 | 0.06% | 268,456 | $33.73 | $33.95 | $33.65 |
| 06 Dec 2024 | $33.72 | $-0.16 | -0.47% | 393,011 | $33.50 | $34.20 | $33.26 |
| 05 Dec 2024 | $33.88 | $0.58 | 1.74% | 406,374 | $33.20 | $33.98 | $33.16 |
| 04 Dec 2024 | $33.30 | $0.01 | 0.03% | 344,707 | $33.05 | $33.43 | $33.03 |
| 03 Dec 2024 | $33.29 | $0.08 | 0.24% | 482,372 | $33.25 | $33.58 | $33.00 |
| 02 Dec 2024 | $33.21 | $0.05 | 0.15% | 232,161 | $33.38 | $33.56 | $33.15 |
| 29 Nov 2024 | $33.16 | $0.09 | 0.27% | 200,223 | $33.10 | $33.23 | $32.88 |
| 28 Nov 2024 | $33.07 | $0.11 | 0.33% | 256,199 | $32.95 | $33.41 | $32.71 |
| 27 Nov 2024 | $32.96 | $0.14 | 0.43% | 245,038 | $32.98 | $33.09 | $32.59 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Nov 2024 | Morten Falkenberg | Buy | 4,500 | $140,895 |
On-market trade.
|
| 20 Sep 2024 | Debra (Debbie) Goodin | Buy | 625 | $19,978 |
On-market trade.
|
| 20 Sep 2024 | Debra (Debbie) Goodin | Buy | 134 | $4,195 |
On-market trade.
|
| 28 Aug 2024 | Nigel Garrard | Buy | 3,413 | $100,683 |
On-market trade.
|
| 15 Aug 2024 | Neil Salmon | Expiry | 36,546 | $983,818 |
As advised by the company. 131,145 Performance Share Rights, lapsed
|
| 13 May 2024 | Nigel Garrard | Buy | 1,337 | $30,015 |
Participation in share purchase plan.
|
| 13 May 2024 | Debra (Debbie) Goodin | Buy | 286 | $6,420 |
Participation in share purchase plan.
|
| 26 Apr 2024 | Christina Stercken | Buy | 627 | $15,657 |
Participation in share purchase plan.
|
| 12 Apr 2024 | Christina Stercken | Buy | 592 | $15,655 |
Participation in share purchase plan.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Nigel David Garrard | Non-Executive Director | Mar 2020 |
Mr Garrard is an executive with a successful track record across FMCG and Industrial/ Manufacturing sectors. Mr Garrard has 20 years of experience as a CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard brings broad international experience across listed, not-for-profit, governance, private and industry entities. Chair of the Governance Committee and Share Buyback Sub-Committee and member of the Human Resources Committee and M&A Sub-Committee.
|
| Mr William G Reilly | Non-Executive Director | Oct 2017 |
Mr Reilly has over 35 years of experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. He is also Member of the Sustainability and Risk Committee, the Human Resources Committee, the Governance Committee and the M&A Sub-Committee.
|
| Ms Debra (Debbie) Lyn Goodin | Non-Executive Director | Dec 2022 |
Ms Goodin is an executive who has global experience in operations, finance, M&A and corporate services, and has worked in both the public and private sectors. Prior to this Ms Goodin was the Global COO of Coffey International where she led a range of engineering consulting businesses in the areas of mining, geotechnics, environment and international development. She is Member of the Compliance Committee and the Human Resources Committee.
|
| Ms Leslie A Desjardins | Non-Executive Director | Nov 2015 |
Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the United States and Australia, including Chief Financial Officer GM Holden, Controller for GM North America and Finance Director for GM's manufacturing facilities in North America. She is Chair of the Compliance Committee, member of the Human Resources Committee and the Governance Committee, M&A Sub-Committee and Share Buyback Sub-Committee.
|
| Mrs Christina Stercken | Non-Executive Director | Oct 2017 |
Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A. Mrs Stercken brings a broad range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. In her function as Vice Chair of Myanmar Foundation, Munich, Mrs Stercken supports social projects in Myanmar. She is Chair of the Sustainability and Risk Committee and M&A Sub-Committee and member of the Compliance Committee.
|
| Ms Christine Yingli Yan | Non-Executive Director | Feb 2019 |
Ms Yan is an executive who has had a distinguished career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. She is Chair of the Human Resources Committee and member of the Sustainability and Risk Committee and the Governance Committee.
|
| Mr Neil Salmon | Chief Executive OfficerManaging Director | Sep 2021 |
Mr Salmon prior to joining Ansell, had more than 20 years of professional experience, gained working across a range of roles in a diverse group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the USA and Singapore before serving as Chief Financial Officer of Innophos in New Jersey, USA.
|
| Morten Falkenberg | Non-Executive Director | Nov 2021 |
Mr Falkenberg is an executive with nearly 35 years of leadership experience within FMCG, Telecoms/ Technology, and consumer durable goods companies most recently as CEO of Nobia from 2010 until his retirement in 2019. Prior to that Mr Falkenberg held senior positions at Electrolux, Tele Denmark and Coca-Cola and has lived outside his native Denmark in the USA, Israel, Norway and Sweden. He is Member of the Compliance Committee and the Sustainability and Risk Committee.
|
| Ms Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary | Apr 2017 |
-
|
| Sean Sweeney | Chief Commercial Officer Americas |
-
|
|
| Augusto Accorsi | Chief Commercial Officer EMEA/APAC |
-
|
|
| Zubair Javeed | Chief Financial Officer |
-
|
|
| Amanda Manzoni | Chief Human Resources Officer |
-
|
|
| Deanna Johnston | Chief Information Officer |
-
|
|
| John Marsden | Chief Operations and Supply Chain Officer |
-
|
|
| Rikard Froberg | Chief Product and Marketing Officer |
-
|
|
| Rob Hughes | Senior Vice President Kimtech and KleenGuard Business Unit |
-
|
|
| Michael Gilleece | Senior Vice-President Corporate General Councel |
-
|
|
| Catherine Stribley | VP Corporate Governance & Social ResponsibilityCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 46,797,269 | 32.07% |
| Citicorp Nominees Pty Limited | 27,412,810 | 18.78% |
| J P Morgan Nominees Australia Pty Limited | 20,079,694 | 13.76% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 4,503,173 | 3.09% |
| National Nominees Limited | 3,660,629 | 2.51% |
| HSBC Custody Nominees (Australia) Limited <Ntcomnwlth Super Corp A/C> | 1,832,201 | 1.26% |
| BNP Paribas Noms Pty Ltd | 1,126,477 | 0.77% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 1,050,073 | 0.72% |
| UBS Nominees Pty Ltd | 711,811 | 0.49% |
| CPU Share Plans Pty Ltd | 686,643 | 0.47% |
| Netwealth Investments Limited <Wrap Services A/C> | 646,870 | 0.44% |
| Ioof Investment Services Limited <Ips Superfund A/C> | 442,519 | 0.30% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 411,319 | 0.28% |
| Netwealth Investments Limited <Super Services A/C> | 375,630 | 0.26% |
| HSBC Custody Nominees (Australia) Limited i | 310,514 | 0.21% |
| HSBC Custody Nominees (Australia) Limited Gsco Eca | 274,068 | 0.19% |
| The Manly Hotels Pty Limited | 224,191 | 0.15% |
| Citicorp Nominees Pty Limited <Dpsl A/C> | 208,344 | 0.14% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 200,252 | 0.14% |
| Ioof Investment Services Limited <Ioof Idps A/C> | 181,090 | 0.12% |
